Fig. 1: Patient numbers, age distribution, SARS-CoV-2 viral load and other viruses present in the adult and pediatric cohorts.
From: Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children
a Number of patients in the SARS-CoV-2, No Virus and Other Virus groups in the adult and pediatric cohorts. Color indicates the age cohort. b Age distribution across the three viral status groups in the adult and pediatric cohorts. Horizontal lines denote the median, box boundaries represent the interquartile range, and whiskers extend to minimum and maximum. Adults-No Virus n = 81, Adults-SARS-CoV-2 n = 45, Adults-Other Virus n = 28, Children-No Virus n = 34, Children-SARS-CoV-2 n = 38, Children-Other Virus n = 11. c Distribution of SARS-CoV-2 viral load, measured in reads-per-million (rpM), in adult (n = 45) and pediatric (n = 38) patients. Horizontal lines denote the median, box boundaries represent the interquartile range, and whiskers extend to minimum and maximum. P-value derives from a two-sided Mann-Whitney test. d Distribution of viruses in the Other Virus groups in the adult and pediatric cohorts. Absolute numbers are provided above each bar, the y-axis indicates percentage out of each cohort’s Other Virus group. One child was infected with both influenza and rhinovirus and two adults were infected with both respiratory syncytial virus and rhinovirus.
